The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Daunorubicin Market Research Report 2024
Synopsis
Daunorubicin is mainly used for acute lymphocytic or myelogenous leukemia resistant to common anti-tumor drugs, but the remission period is short, so it needs to be combined with other drugs.It is orange-red acicular crystal, easily soluble in water.Its aqueous solution is quite stable and can be kept at 0℃ or 37℃ for 3 weeks without changing its activity.The effect is the same as adriamycin, embedded DNA, can inhibit the synthesis of RNA and DNA, the effect on RNA is particularly obvious, selective effect on purine nucleoside.
The global Daunorubicin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Daunorubicin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Daunorubicin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Daunorubicin include Sanofi, Halison Pharmaceuiticals, Hikma Pharmaceuticals, Gilead Sciences, Bedford Pharmaceuticals, United Biotech, Mercian Corporation, Pharmacia and Cipla, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Daunorubicin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Daunorubicin.
Report Scope
The Daunorubicin market size, estimations, and forecasts are provided in terms of sales volume (Litre) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Daunorubicin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Daunorubicin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Halison Pharmaceuiticals
Hikma Pharmaceuticals
Gilead Sciences
Bedford Pharmaceuticals
United Biotech
Mercian Corporation
Pharmacia
Cipla
TEVA
Medior Healthcare
West-Ward
Shandong Xinshidai Pharmaceutical
HISUN
Shenzhen Wanle Pharmaceutical
Segment by Type
Intravenous
Drip
Segment by Application
Acute Granulocyte
Acute Lymphocyte Leukemia
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Daunorubicin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Daunorubicin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Daunorubicin is mainly used for acute lymphocytic or myelogenous leukemia resistant to common anti-tumor drugs, but the remission period is short, so it needs to be combined with other drugs.It is orange-red acicular crystal, easily soluble in water.Its aqueous solution is quite stable and can be kept at 0℃ or 37℃ for 3 weeks without changing its activity.The effect is the same as adriamycin, embedded DNA, can inhibit the synthesis of RNA and DNA, the effect on RNA is particularly obvious, selective effect on purine nucleoside.
The global Daunorubicin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Daunorubicin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Daunorubicin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Daunorubicin include Sanofi, Halison Pharmaceuiticals, Hikma Pharmaceuticals, Gilead Sciences, Bedford Pharmaceuticals, United Biotech, Mercian Corporation, Pharmacia and Cipla, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Daunorubicin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Daunorubicin.
Report Scope
The Daunorubicin market size, estimations, and forecasts are provided in terms of sales volume (Litre) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Daunorubicin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Daunorubicin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Halison Pharmaceuiticals
Hikma Pharmaceuticals
Gilead Sciences
Bedford Pharmaceuticals
United Biotech
Mercian Corporation
Pharmacia
Cipla
TEVA
Medior Healthcare
West-Ward
Shandong Xinshidai Pharmaceutical
HISUN
Shenzhen Wanle Pharmaceutical
Segment by Type
Intravenous
Drip
Segment by Application
Acute Granulocyte
Acute Lymphocyte Leukemia
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Daunorubicin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Daunorubicin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Daunorubicin Market Overview
1.1 Product Overview and Scope of Daunorubicin
1.2 Daunorubicin Segment by Type
1.2.1 Global Daunorubicin Market Value Comparison by Type (2024-2030)
1.2.2 Intravenous
1.2.3 Drip
1.3 Daunorubicin Segment by Application
1.3.1 Global Daunorubicin Market Value by Application: (2024-2030)
1.3.2 Acute Granulocyte
1.3.3 Acute Lymphocyte Leukemia
1.4 Global Daunorubicin Market Size Estimates and Forecasts
1.4.1 Global Daunorubicin Revenue 2019-2030
1.4.2 Global Daunorubicin Sales 2019-2030
1.4.3 Global Daunorubicin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Daunorubicin Market Competition by Manufacturers
2.1 Global Daunorubicin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Daunorubicin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Daunorubicin Average Price by Manufacturers (2019-2024)
2.4 Global Daunorubicin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Daunorubicin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Daunorubicin, Product Type & Application
2.7 Daunorubicin Market Competitive Situation and Trends
2.7.1 Daunorubicin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Daunorubicin Players Market Share by Revenue
2.7.3 Global Daunorubicin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Daunorubicin Retrospective Market Scenario by Region
3.1 Global Daunorubicin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Daunorubicin Global Daunorubicin Sales by Region: 2019-2030
3.2.1 Global Daunorubicin Sales by Region: 2019-2024
3.2.2 Global Daunorubicin Sales by Region: 2025-2030
3.3 Global Daunorubicin Global Daunorubicin Revenue by Region: 2019-2030
3.3.1 Global Daunorubicin Revenue by Region: 2019-2024
3.3.2 Global Daunorubicin Revenue by Region: 2025-2030
3.4 North America Daunorubicin Market Facts & Figures by Country
3.4.1 North America Daunorubicin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Daunorubicin Sales by Country (2019-2030)
3.4.3 North America Daunorubicin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Daunorubicin Market Facts & Figures by Country
3.5.1 Europe Daunorubicin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Daunorubicin Sales by Country (2019-2030)
3.5.3 Europe Daunorubicin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Daunorubicin Market Facts & Figures by Country
3.6.1 Asia Pacific Daunorubicin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Daunorubicin Sales by Country (2019-2030)
3.6.3 Asia Pacific Daunorubicin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Daunorubicin Market Facts & Figures by Country
3.7.1 Latin America Daunorubicin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Daunorubicin Sales by Country (2019-2030)
3.7.3 Latin America Daunorubicin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Daunorubicin Market Facts & Figures by Country
3.8.1 Middle East and Africa Daunorubicin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Daunorubicin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Daunorubicin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Daunorubicin Sales by Type (2019-2030)
4.1.1 Global Daunorubicin Sales by Type (2019-2024)
4.1.2 Global Daunorubicin Sales by Type (2025-2030)
4.1.3 Global Daunorubicin Sales Market Share by Type (2019-2030)
4.2 Global Daunorubicin Revenue by Type (2019-2030)
4.2.1 Global Daunorubicin Revenue by Type (2019-2024)
4.2.2 Global Daunorubicin Revenue by Type (2025-2030)
4.2.3 Global Daunorubicin Revenue Market Share by Type (2019-2030)
4.3 Global Daunorubicin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Daunorubicin Sales by Application (2019-2030)
5.1.1 Global Daunorubicin Sales by Application (2019-2024)
5.1.2 Global Daunorubicin Sales by Application (2025-2030)
5.1.3 Global Daunorubicin Sales Market Share by Application (2019-2030)
5.2 Global Daunorubicin Revenue by Application (2019-2030)
5.2.1 Global Daunorubicin Revenue by Application (2019-2024)
5.2.2 Global Daunorubicin Revenue by Application (2025-2030)
5.2.3 Global Daunorubicin Revenue Market Share by Application (2019-2030)
5.3 Global Daunorubicin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Daunorubicin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Daunorubicin Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Halison Pharmaceuiticals
6.2.1 Halison Pharmaceuiticals Corporation Information
6.2.2 Halison Pharmaceuiticals Description and Business Overview
6.2.3 Halison Pharmaceuiticals Daunorubicin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Halison Pharmaceuiticals Daunorubicin Product Portfolio
6.2.5 Halison Pharmaceuiticals Recent Developments/Updates
6.3 Hikma Pharmaceuticals
6.3.1 Hikma Pharmaceuticals Corporation Information
6.3.2 Hikma Pharmaceuticals Description and Business Overview
6.3.3 Hikma Pharmaceuticals Daunorubicin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hikma Pharmaceuticals Daunorubicin Product Portfolio
6.3.5 Hikma Pharmaceuticals Recent Developments/Updates
6.4 Gilead Sciences
6.4.1 Gilead Sciences Corporation Information
6.4.2 Gilead Sciences Description and Business Overview
6.4.3 Gilead Sciences Daunorubicin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Gilead Sciences Daunorubicin Product Portfolio
6.4.5 Gilead Sciences Recent Developments/Updates
6.5 Bedford Pharmaceuticals
6.5.1 Bedford Pharmaceuticals Corporation Information
6.5.2 Bedford Pharmaceuticals Description and Business Overview
6.5.3 Bedford Pharmaceuticals Daunorubicin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bedford Pharmaceuticals Daunorubicin Product Portfolio
6.5.5 Bedford Pharmaceuticals Recent Developments/Updates
6.6 United Biotech
6.6.1 United Biotech Corporation Information
6.6.2 United Biotech Description and Business Overview
6.6.3 United Biotech Daunorubicin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 United Biotech Daunorubicin Product Portfolio
6.6.5 United Biotech Recent Developments/Updates
6.7 Mercian Corporation
6.6.1 Mercian Corporation Corporation Information
6.6.2 Mercian Corporation Description and Business Overview
6.6.3 Mercian Corporation Daunorubicin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mercian Corporation Daunorubicin Product Portfolio
6.7.5 Mercian Corporation Recent Developments/Updates
6.8 Pharmacia
6.8.1 Pharmacia Corporation Information
6.8.2 Pharmacia Description and Business Overview
6.8.3 Pharmacia Daunorubicin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pharmacia Daunorubicin Product Portfolio
6.8.5 Pharmacia Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Corporation Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Daunorubicin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cipla Daunorubicin Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 TEVA
6.10.1 TEVA Corporation Information
6.10.2 TEVA Description and Business Overview
6.10.3 TEVA Daunorubicin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 TEVA Daunorubicin Product Portfolio
6.10.5 TEVA Recent Developments/Updates
6.11 Medior Healthcare
6.11.1 Medior Healthcare Corporation Information
6.11.2 Medior Healthcare Daunorubicin Description and Business Overview
6.11.3 Medior Healthcare Daunorubicin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Medior Healthcare Daunorubicin Product Portfolio
6.11.5 Medior Healthcare Recent Developments/Updates
6.12 West-Ward
6.12.1 West-Ward Corporation Information
6.12.2 West-Ward Daunorubicin Description and Business Overview
6.12.3 West-Ward Daunorubicin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 West-Ward Daunorubicin Product Portfolio
6.12.5 West-Ward Recent Developments/Updates
6.13 Shandong Xinshidai Pharmaceutical
6.13.1 Shandong Xinshidai Pharmaceutical Corporation Information
6.13.2 Shandong Xinshidai Pharmaceutical Daunorubicin Description and Business Overview
6.13.3 Shandong Xinshidai Pharmaceutical Daunorubicin Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Shandong Xinshidai Pharmaceutical Daunorubicin Product Portfolio
6.13.5 Shandong Xinshidai Pharmaceutical Recent Developments/Updates
6.14 HISUN
6.14.1 HISUN Corporation Information
6.14.2 HISUN Daunorubicin Description and Business Overview
6.14.3 HISUN Daunorubicin Sales, Revenue and Gross Margin (2019-2024)
6.14.4 HISUN Daunorubicin Product Portfolio
6.14.5 HISUN Recent Developments/Updates
6.15 Shenzhen Wanle Pharmaceutical
6.15.1 Shenzhen Wanle Pharmaceutical Corporation Information
6.15.2 Shenzhen Wanle Pharmaceutical Daunorubicin Description and Business Overview
6.15.3 Shenzhen Wanle Pharmaceutical Daunorubicin Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Shenzhen Wanle Pharmaceutical Daunorubicin Product Portfolio
6.15.5 Shenzhen Wanle Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Daunorubicin Industry Chain Analysis
7.2 Daunorubicin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Daunorubicin Production Mode & Process
7.4 Daunorubicin Sales and Marketing
7.4.1 Daunorubicin Sales Channels
7.4.2 Daunorubicin Distributors
7.5 Daunorubicin Customers
8 Daunorubicin Market Dynamics
8.1 Daunorubicin Industry Trends
8.2 Daunorubicin Market Drivers
8.3 Daunorubicin Market Challenges
8.4 Daunorubicin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Daunorubicin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Daunorubicin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Daunorubicin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Daunorubicin Sales (Litre) of Key Manufacturers (2019-2024)
Table 5. Global Daunorubicin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Daunorubicin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Daunorubicin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Daunorubicin Average Price (US$/Litre) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Daunorubicin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Daunorubicin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Daunorubicin, Product Type & Application
Table 12. Global Key Manufacturers of Daunorubicin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Daunorubicin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Daunorubicin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Daunorubicin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Daunorubicin Sales by Region (2019-2024) & (Litre)
Table 18. Global Daunorubicin Sales Market Share by Region (2019-2024)
Table 19. Global Daunorubicin Sales by Region (2025-2030) & (Litre)
Table 20. Global Daunorubicin Sales Market Share by Region (2025-2030)
Table 21. Global Daunorubicin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Daunorubicin Revenue Market Share by Region (2019-2024)
Table 23. Global Daunorubicin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Daunorubicin Revenue Market Share by Region (2025-2030)
Table 25. North America Daunorubicin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Daunorubicin Sales by Country (2019-2024) & (Litre)
Table 27. North America Daunorubicin Sales by Country (2025-2030) & (Litre)
Table 28. North America Daunorubicin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Daunorubicin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Daunorubicin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Daunorubicin Sales by Country (2019-2024) & (Litre)
Table 32. Europe Daunorubicin Sales by Country (2025-2030) & (Litre)
Table 33. Europe Daunorubicin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Daunorubicin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Daunorubicin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Daunorubicin Sales by Region (2019-2024) & (Litre)
Table 37. Asia Pacific Daunorubicin Sales by Region (2025-2030) & (Litre)
Table 38. Asia Pacific Daunorubicin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Daunorubicin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Daunorubicin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Daunorubicin Sales by Country (2019-2024) & (Litre)
Table 42. Latin America Daunorubicin Sales by Country (2025-2030) & (Litre)
Table 43. Latin America Daunorubicin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Daunorubicin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Daunorubicin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Daunorubicin Sales by Country (2019-2024) & (Litre)
Table 47. Middle East & Africa Daunorubicin Sales by Country (2025-2030) & (Litre)
Table 48. Middle East & Africa Daunorubicin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Daunorubicin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Daunorubicin Sales (Litre) by Type (2019-2024)
Table 51. Global Daunorubicin Sales (Litre) by Type (2025-2030)
Table 52. Global Daunorubicin Sales Market Share by Type (2019-2024)
Table 53. Global Daunorubicin Sales Market Share by Type (2025-2030)
Table 54. Global Daunorubicin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Daunorubicin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Daunorubicin Revenue Market Share by Type (2019-2024)
Table 57. Global Daunorubicin Revenue Market Share by Type (2025-2030)
Table 58. Global Daunorubicin Price (US$/Litre) by Type (2019-2024)
Table 59. Global Daunorubicin Price (US$/Litre) by Type (2025-2030)
Table 60. Global Daunorubicin Sales (Litre) by Application (2019-2024)
Table 61. Global Daunorubicin Sales (Litre) by Application (2025-2030)
Table 62. Global Daunorubicin Sales Market Share by Application (2019-2024)
Table 63. Global Daunorubicin Sales Market Share by Application (2025-2030)
Table 64. Global Daunorubicin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Daunorubicin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Daunorubicin Revenue Market Share by Application (2019-2024)
Table 67. Global Daunorubicin Revenue Market Share by Application (2025-2030)
Table 68. Global Daunorubicin Price (US$/Litre) by Application (2019-2024)
Table 69. Global Daunorubicin Price (US$/Litre) by Application (2025-2030)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 73. Sanofi Daunorubicin Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Halison Pharmaceuiticals Corporation Information
Table 76. Halison Pharmaceuiticals Description and Business Overview
Table 77. Halison Pharmaceuiticals Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 78. Halison Pharmaceuiticals Daunorubicin Product
Table 79. Halison Pharmaceuiticals Recent Developments/Updates
Table 80. Hikma Pharmaceuticals Corporation Information
Table 81. Hikma Pharmaceuticals Description and Business Overview
Table 82. Hikma Pharmaceuticals Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 83. Hikma Pharmaceuticals Daunorubicin Product
Table 84. Hikma Pharmaceuticals Recent Developments/Updates
Table 85. Gilead Sciences Corporation Information
Table 86. Gilead Sciences Description and Business Overview
Table 87. Gilead Sciences Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 88. Gilead Sciences Daunorubicin Product
Table 89. Gilead Sciences Recent Developments/Updates
Table 90. Bedford Pharmaceuticals Corporation Information
Table 91. Bedford Pharmaceuticals Description and Business Overview
Table 92. Bedford Pharmaceuticals Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 93. Bedford Pharmaceuticals Daunorubicin Product
Table 94. Bedford Pharmaceuticals Recent Developments/Updates
Table 95. United Biotech Corporation Information
Table 96. United Biotech Description and Business Overview
Table 97. United Biotech Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 98. United Biotech Daunorubicin Product
Table 99. United Biotech Recent Developments/Updates
Table 100. Mercian Corporation Corporation Information
Table 101. Mercian Corporation Description and Business Overview
Table 102. Mercian Corporation Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 103. Mercian Corporation Daunorubicin Product
Table 104. Mercian Corporation Recent Developments/Updates
Table 105. Pharmacia Corporation Information
Table 106. Pharmacia Description and Business Overview
Table 107. Pharmacia Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 108. Pharmacia Daunorubicin Product
Table 109. Pharmacia Recent Developments/Updates
Table 110. Cipla Corporation Information
Table 111. Cipla Description and Business Overview
Table 112. Cipla Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 113. Cipla Daunorubicin Product
Table 114. Cipla Recent Developments/Updates
Table 115. TEVA Corporation Information
Table 116. TEVA Description and Business Overview
Table 117. TEVA Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 118. TEVA Daunorubicin Product
Table 119. TEVA Recent Developments/Updates
Table 120. Medior Healthcare Corporation Information
Table 121. Medior Healthcare Description and Business Overview
Table 122. Medior Healthcare Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 123. Medior Healthcare Daunorubicin Product
Table 124. Medior Healthcare Recent Developments/Updates
Table 125. West-Ward Corporation Information
Table 126. West-Ward Description and Business Overview
Table 127. West-Ward Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 128. West-Ward Daunorubicin Product
Table 129. West-Ward Recent Developments/Updates
Table 130. Shandong Xinshidai Pharmaceutical Corporation Information
Table 131. Shandong Xinshidai Pharmaceutical Description and Business Overview
Table 132. Shandong Xinshidai Pharmaceutical Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 133. Shandong Xinshidai Pharmaceutical Daunorubicin Product
Table 134. Shandong Xinshidai Pharmaceutical Recent Developments/Updates
Table 135. HISUN Corporation Information
Table 136. HISUN Description and Business Overview
Table 137. HISUN Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 138. HISUN Daunorubicin Product
Table 139. HISUN Recent Developments/Updates
Table 140. Shenzhen Wanle Pharmaceutical Corporation Information
Table 141. Shenzhen Wanle Pharmaceutical Description and Business Overview
Table 142. Shenzhen Wanle Pharmaceutical Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 143. Shenzhen Wanle Pharmaceutical Daunorubicin Product
Table 144. Shenzhen Wanle Pharmaceutical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Daunorubicin Distributors List
Table 148. Daunorubicin Customers List
Table 149. Daunorubicin Market Trends
Table 150. Daunorubicin Market Drivers
Table 151. Daunorubicin Market Challenges
Table 152. Daunorubicin Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Daunorubicin
Figure 2. Global Daunorubicin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Daunorubicin Market Share by Type in 2023 & 2030
Figure 4. Intravenous Product Picture
Figure 5. Drip Product Picture
Figure 6. Global Daunorubicin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Daunorubicin Market Share by Application in 2023 & 2030
Figure 8. Acute Granulocyte
Figure 9. Acute Lymphocyte Leukemia
Figure 10. Global Daunorubicin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Daunorubicin Market Size (2019-2030) & (US$ Million)
Figure 12. Global Daunorubicin Sales (2019-2030) & (Litre)
Figure 13. Global Daunorubicin Average Price (US$/Litre) & (2019-2030)
Figure 14. Daunorubicin Report Years Considered
Figure 15. Daunorubicin Sales Share by Manufacturers in 2023
Figure 16. Global Daunorubicin Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Daunorubicin Players: Market Share by Revenue in 2023
Figure 18. Daunorubicin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Daunorubicin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Daunorubicin Sales Market Share by Country (2019-2030)
Figure 21. North America Daunorubicin Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Daunorubicin Sales Market Share by Country (2019-2030)
Figure 25. Europe Daunorubicin Revenue Market Share by Country (2019-2030)
Figure 26. Germany Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Daunorubicin Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Daunorubicin Revenue Market Share by Region (2019-2030)
Figure 33. China Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Daunorubicin Sales Market Share by Country (2019-2030)
Figure 44. Latin America Daunorubicin Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Daunorubicin Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Daunorubicin Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Daunorubicin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Daunorubicin by Type (2019-2030)
Figure 54. Global Revenue Market Share of Daunorubicin by Type (2019-2030)
Figure 55. Global Daunorubicin Price (US$/Litre) by Type (2019-2030)
Figure 56. Global Sales Market Share of Daunorubicin by Application (2019-2030)
Figure 57. Global Revenue Market Share of Daunorubicin by Application (2019-2030)
Figure 58. Global Daunorubicin Price (US$/Litre) by Application (2019-2030)
Figure 59. Daunorubicin Value Chain
Figure 60. Daunorubicin Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
